A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

Anti-amyloid treatments are best suited for people in the early stages of Alzheimer’s disease. Amyloid plaques begin to form as many as 20 years before the appearance of any Alzheimer’s symptoms.

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

Hope is on the horizon as a new review indicates a growing number of potential treatments for Alzheimer’s disease.. The review, spearheaded by a University of Nevada expert and featured in the ...

The study, published March 6 in Nature Medicine, shows that the brain’s immune cells, called microglia, play a more powerful ...

June is Alzheimer's and Brain Awareness Month. With an estimated 55 million people living with Alzheimer's Disease and other ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

Helicobacter pylori, best known for causing stomach ulcers, was shown to block the build-up of both amyloid-beta and tau in our study.

David Olsen, Director of State Affairs for the Alzheimer’s Association, joins Lisa Dent to talk about Illinois becoming the first state to require insurance to provide coverage for ...